PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.55%
Revenue growth under 50% of CX's 17.43%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-68.24%
Negative gross profit growth while CX is at 24.07%. Joel Greenblatt would examine cost competitiveness or demand decline.
-91.94%
Negative EBIT growth while CX is at 54.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-91.94%
Negative operating income growth while CX is at 54.93%. Joel Greenblatt would press for urgent turnaround measures.
3.82%
Net income growth under 50% of CX's 14.59%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.17%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2.17%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.35%
Slight or no buybacks while CX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.30%
Slight or no buyback while CX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
333.98%
Positive 10Y revenue/share CAGR while CX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
110.69%
5Y revenue/share CAGR 1.25-1.5x CX's 74.91%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
91.60%
3Y revenue/share CAGR at 50-75% of CX's 124.65%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
328.52%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
244.12%
Positive 5Y CAGR while CX is negative. John Neff might view this as a strong mid-term relative advantage.
270.44%
3Y net income/share CAGR above 1.5x CX's 69.23%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
63.86%
5Y equity/share CAGR above 1.5x CX's 28.33%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
50.79%
3Y equity/share CAGR at 75-90% of CX's 65.98%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.